1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Infectious Testing 1.2.3 Diabetes Testing 1.2.4 Molecular Testing 1.2.5 Tissue Testing 1.3 Market by Application 1.3.1 Global In-vitro Diagnostic Services Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Point-Of-Care Testing 1.3.4 Laboratories 1.3.5 Academic Institutes 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global In-vitro Diagnostic Services Market Size (2017-2028) 2.2 In-vitro Diagnostic Services Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global In-vitro Diagnostic Services Market Size by Region (2017-2022) 2.4 Global In-vitro Diagnostic Services Market Size Forecast by Region (2023-2028) 2.5 Global Top In-vitro Diagnostic Services Countries Ranking by Market Size 3 In-vitro Diagnostic Services Competitive by Company 3.1 Global In-vitro Diagnostic Services Revenue by Players 3.1.1 Global In-vitro Diagnostic Services Revenue by Players (2017-2022) 3.1.2 Global In-vitro Diagnostic Services Market Share by Players (2017-2022) 3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by In-vitro Diagnostic Services Revenue 3.4 Global In-vitro Diagnostic Services Market Concentration Ratio 3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2021 3.5 Global In-vitro Diagnostic Services Key Players Head office and Area Served 3.6 Key Players In-vitro Diagnostic Services Product Solution and Service 3.7 Date of Enter into In-vitro Diagnostic Services Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global In-vitro Diagnostic Services Breakdown Data by Type 4.1 Global In-vitro Diagnostic Services Historic Revenue by Type (2017-2022) 4.2 Global In-vitro Diagnostic Services Forecasted Revenue by Type (2023-2028) 5 Global In-vitro Diagnostic Services Breakdown Data by Application 5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2017-2022) 5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America In-vitro Diagnostic Services Revenue by Company (2020-2022) 6.2 North America In-vitro Diagnostic Services Revenue by Type (2017-2028) 6.3 North America In-vitro Diagnostic Services Revenue by Application (2017-2028) 6.4 North America In-vitro Diagnostic Services Revenue by Country (2017-2028) 6.4.1 United States 6.4.2 Canada 6.4.3 Mexico 7 Europe 7.1 Europe In-vitro Diagnostic Services Revenue by Company (2020-2022) 7.2 Europe In-vitro Diagnostic Services Revenue by Type (2017-2028) 7.3 Europe In-vitro Diagnostic Services Revenue by Application (2017-2028) 7.4 Europe In-vitro Diagnostic Services Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 UK 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific In-vitro Diagnostic Services Revenue by Company (2020-2022) 8.2 Asia Pacific In-vitro Diagnostic Services Revenue by Type (2017-2028) 8.3 Asia Pacific In-vitro Diagnostic Services Revenue by Application (2017-2028) 8.4 Asia Pacific In-vitro Diagnostic Services Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 China Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 9 Latin America 9.1 Latin America In-vitro Diagnostic Services Revenue by Company (2020-2022) 9.2 Latin America In-vitro Diagnostic Services Revenue by Type (2017-2028) 9.3 Latin America In-vitro Diagnostic Services Revenue by Application (2017-2028) 9.4 Latin America In-vitro Diagnostic Services Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa In-vitro Diagnostic Services Revenue by Company (2020-2022) 10.2 Middle East and Africa In-vitro Diagnostic Services Revenue by Type (2017-2028) 10.3 Middle East and Africa In-vitro Diagnostic Services Revenue by Application (2017-2028) 10.4 Middle East and Africa In-vitro Diagnostic Services Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 BioRad 11.1.1 BioRad Company Details 11.1.2 BioRad Business Overview 11.1.3 BioRad In-vitro Diagnostic Services Products and Services 11.1.4 BioRad In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.1.5 BioRad In-vitro Diagnostic Services SWOT Analysis 11.1.6 BioRad Recent Developments 11.2 DexCom 11.2.1 DexCom Company Details 11.2.2 DexCom Business Overview 11.2.3 DexCom In-vitro Diagnostic Services Products and Services 11.2.4 DexCom In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.2.5 DexCom In-vitro Diagnostic Services SWOT Analysis 11.2.6 DexCom Recent Developments 11.3 Nova Biomedical 11.3.1 Nova Biomedical Company Details 11.3.2 Nova Biomedical Business Overview 11.3.3 Nova Biomedical In-vitro Diagnostic Services Products and Services 11.3.4 Nova Biomedical In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.3.5 Nova Biomedical In-vitro Diagnostic Services SWOT Analysis 11.3.6 Nova Biomedical Recent Developments 11.4 OraSure 11.4.1 OraSure Company Details 11.4.2 OraSure Business Overview 11.4.3 OraSure In-vitro Diagnostic Services Products and Services 11.4.4 OraSure In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.4.5 OraSure In-vitro Diagnostic Services SWOT Analysis 11.4.6 OraSure Recent Developments 11.5 Pearl Pathways 11.5.1 Pearl Pathways Company Details 11.5.2 Pearl Pathways Business Overview 11.5.3 Pearl Pathways In-vitro Diagnostic Services Products and Services 11.5.4 Pearl Pathways In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.5.5 Pearl Pathways In-vitro Diagnostic Services SWOT Analysis 11.5.6 Pearl Pathways Recent Developments 11.6 Phenomenex 11.6.1 Phenomenex Company Details 11.6.2 Phenomenex Business Overview 11.6.3 Phenomenex In-vitro Diagnostic Services Products and Services 11.6.4 Phenomenex In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.6.5 Phenomenex In-vitro Diagnostic Services SWOT Analysis 11.6.6 Phenomenex Recent Developments 11.7 Qiagen 11.7.1 Qiagen Company Details 11.7.2 Qiagen Business Overview 11.7.3 Qiagen In-vitro Diagnostic Services Products and Services 11.7.4 Qiagen In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.7.5 Qiagen In-vitro Diagnostic Services SWOT Analysis 11.7.6 Qiagen Recent Developments 11.8 Roche Diagnostics 11.8.1 Roche Diagnostics Company Details 11.8.2 Roche Diagnostics Business Overview 11.8.3 Roche Diagnostics In-vitro Diagnostic Services Products and Services 11.8.4 Roche Diagnostics In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.8.5 Roche Diagnostics In-vitro Diagnostic Services SWOT Analysis 11.8.6 Roche Diagnostics Recent Developments 11.9 Siemens 11.9.1 Siemens Company Details 11.9.2 Siemens Business Overview 11.9.3 Siemens In-vitro Diagnostic Services Products and Services 11.9.4 Siemens In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.9.5 Siemens In-vitro Diagnostic Services SWOT Analysis 11.9.6 Siemens Recent Developments 11.10 Sysmex 11.10.1 Sysmex Company Details 11.10.2 Sysmex Business Overview 11.10.3 Sysmex In-vitro Diagnostic Services Products and Services 11.10.4 Sysmex In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.10.5 Sysmex In-vitro Diagnostic Services SWOT Analysis 11.10.6 Sysmex Recent Developments 11.11 Thermofisher 11.11.1 Thermofisher Company Details 11.11.2 Thermofisher Business Overview 11.11.3 Thermofisher In-vitro Diagnostic Services Products and Services 11.11.4 Thermofisher In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) 11.11.5 Thermofisher Recent Developments 12 In-vitro Diagnostic Services Market Dynamics 12.1 In-vitro Diagnostic Services Market Trends 12.2 In-vitro Diagnostic Services Market Drivers 12.3 In-vitro Diagnostic Services Market Challenges 12.4 In-vitro Diagnostic Services Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global In-vitro Diagnostic Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Infectious Testing Table 3. Key Players of Diabetes Testing Table 4. Key Players of Molecular Testing Table 5. Key Players of Tissue Testing Table 6. Global In-vitro Diagnostic Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global In-vitro Diagnostic Services Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 8. Global In-vitro Diagnostic Services Revenue by Region (2017-2022) & (US$ Million) Table 9. Global In-vitro Diagnostic Services Revenue Market Share by Region (2017-2022) Table 10. Global In-vitro Diagnostic Services Revenue by Players (2017-2022) & (US$ Million) Table 11. Global In-vitro Diagnostic Services Market Share by Players (2017-2022) Table 12. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2021) Table 13. Ranking of Global Top In-vitro Diagnostic Services Companies by Revenue (US$ Million) in 2021 Table 14. Global 5 Largest Players Market Share by In-vitro Diagnostic Services Revenue (CR5 and HHI) & (2017-2022) Table 15. Key Players Headquarters and Area Served Table 16. Key Players In-vitro Diagnostic Services Product Solution and Service Table 17. Date of Key Manufacturers Enter into In-vitro Diagnostic Services Market Table 18. Mergers & Acquisitions, Expansion Plans Table 19. Global In-vitro Diagnostic Services Market Size by Type (2017-2022) & (US$ Million) Table 20. Global In-vitro Diagnostic Services Revenue Market Share by Type (2017-2022) Table 21. Global In-vitro Diagnostic Services Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 22. Global In-vitro Diagnostic Services Revenue Market Share by Type (2023-2028) Table 23. Global In-vitro Diagnostic Services Market Size by Application (2017-2022) & (US$ Million) Table 24. Global In-vitro Diagnostic Services Revenue Market Share by Application (2017-2022) Table 25. Global In-vitro Diagnostic Services Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 26. Global In-vitro Diagnostic Services Revenue Market Share by Application (2023-2028) Table 27. North America In-vitro Diagnostic Services Revenue by Company (2020-2022) & (US$ Million) Table 28. North America In-vitro Diagnostic Services Revenue by Type (2017-2022) & (US$ Million) Table 29. North America In-vitro Diagnostic Services Revenue by Type (2023-2028) & (US$ Million) Table 30. North America In-vitro Diagnostic Services Revenue by Application (2017-2022) & (US$ Million) Table 31. North America In-vitro Diagnostic Services Revenue by Application (2023-2028) & (US$ Million) Table 32. North America In-vitro Diagnostic Services Revenue by Country (2017-2022) & (US$ Million) Table 33. North America In-vitro Diagnostic Services Revenue by Country (2023-2028) & (US$ Million) Table 34. Europe In-vitro Diagnostic Services Revenue by Company (2020-2022) & (US$ Million) Table 35. Europe In-vitro Diagnostic Services Revenue by Type (2017-2022) & (US$ Million) Table 36. Europe In-vitro Diagnostic Services Revenue by Type (2023-2028) & (US$ Million) Table 37. Europe In-vitro Diagnostic Services Revenue by Application (2017-2022) & (US$ Million) Table 38. Europe In-vitro Diagnostic Services Revenue by Application (2023-2028) & (US$ Million) Table 39. Europe In-vitro Diagnostic Services Revenue by Country (2017-2022) & (US$ Million) Table 40. Europe In-vitro Diagnostic Services Revenue by Country (2023-2028) & (US$ Million) Table 41. Asia Pacific In-vitro Diagnostic Services Revenue by Company (2020-2022) & (US$ Million) Table 42. Asia Pacific In-vitro Diagnostic Services Revenue by Type (2017-2022) & (US$ Million) Table 43. Asia Pacific In-vitro Diagnostic Services Revenue by Type (2023-2028) & (US$ Million) Table 44. Asia Pacific In-vitro Diagnostic Services Revenue by Application (2017-2022) & (US$ Million) Table 45. Asia Pacific In-vitro Diagnostic Services Revenue by Application (2023-2028) & (US$ Million) Table 46. Asia Pacific In-vitro Diagnostic Services Revenue by Region (2017-2022) & (US$ Million) Table 47. Asia Pacific In-vitro Diagnostic Services Revenue by Region (2023-2028) & (US$ Million) Table 48. Latin America In-vitro Diagnostic Services Revenue by Company (2020-2022) & (US$ Million) Table 49. Latin America In-vitro Diagnostic Services Revenue by Type (2017-2022) & (US$ Million) Table 50. Latin America In-vitro Diagnostic Services Revenue by Type (2023-2028) & (US$ Million) Table 51. Latin America In-vitro Diagnostic Services Revenue by Application (2017-2022) & (US$ Million) Table 52. Latin America In-vitro Diagnostic Services Revenue by Application (2023-2028) & (US$ Million) Table 53. Latin America In-vitro Diagnostic Services Revenue by Country (2017-2022) & (US$ Million) Table 54. Latin America In-vitro Diagnostic Services Revenue by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa In-vitro Diagnostic Services Revenue by Company (2020-2022) & (US$ Million) Table 56. Middle East and Africa In-vitro Diagnostic Services Revenue by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa In-vitro Diagnostic Services Revenue by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa In-vitro Diagnostic Services Revenue by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa In-vitro Diagnostic Services Revenue by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa In-vitro Diagnostic Services Revenue by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa In-vitro Diagnostic Services Revenue by Country (2023-2028) & (US$ Million) Table 62. BioRad Company Details Table 63. BioRad Business Overview Table 64. BioRad In-vitro Diagnostic Services Product and Services Table 65. BioRad In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 66. BioRad In-vitro Diagnostic Services SWOT Analysis Table 67. BioRad Recent Developments Table 68. DexCom Company Details Table 69. DexCom Business Overview Table 70. DexCom In-vitro Diagnostic Services Product and Services Table 71. DexCom In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 72. DexCom In-vitro Diagnostic Services SWOT Analysis Table 73. DexCom Recent Developments Table 74. Nova Biomedical Company Details Table 75. Nova Biomedical Business Overview Table 76. Nova Biomedical In-vitro Diagnostic Services Product and Services Table 77. Nova Biomedical In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 78. Nova Biomedical In-vitro Diagnostic Services SWOT Analysis Table 79. Nova Biomedical Recent Developments Table 80. OraSure Company Details Table 81. OraSure Business Overview Table 82. OraSure In-vitro Diagnostic Services Product and Services Table 83. OraSure In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 84. OraSure In-vitro Diagnostic Services SWOT Analysis Table 85. OraSure Recent Developments Table 86. Pearl Pathways Company Details Table 87. Pearl Pathways Business Overview Table 88. Pearl Pathways In-vitro Diagnostic Services Product and Services Table 89. Pearl Pathways In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 90. Pearl Pathways In-vitro Diagnostic Services SWOT Analysis Table 91. Pearl Pathways Recent Developments Table 92. Phenomenex Company Details Table 93. Phenomenex Business Overview Table 94. Phenomenex In-vitro Diagnostic Services Product and Services Table 95. Phenomenex In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 96. Phenomenex In-vitro Diagnostic Services SWOT Analysis Table 97. Phenomenex Recent Developments Table 98. Qiagen Company Details Table 99. Qiagen Business Overview Table 100. Qiagen In-vitro Diagnostic Services Product and Services Table 101. Qiagen In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 102. Qiagen In-vitro Diagnostic Services SWOT Analysis Table 103. Qiagen Recent Developments Table 104. Roche Diagnostics Company Details Table 105. Roche Diagnostics Business Overview Table 106. Roche Diagnostics In-vitro Diagnostic Services Product and Services Table 107. Roche Diagnostics In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 108. Roche Diagnostics In-vitro Diagnostic Services SWOT Analysis Table 109. Roche Diagnostics Recent Developments Table 110. Siemens Company Details Table 111. Siemens Business Overview Table 112. Siemens In-vitro Diagnostic Services Product and Services Table 113. Siemens In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 114. Siemens In-vitro Diagnostic Services SWOT Analysis Table 115. Siemens Recent Developments Table 116. Sysmex Company Details Table 117. Sysmex Business Overview Table 118. Sysmex In-vitro Diagnostic Services Product and Services Table 119. Sysmex In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 120. Sysmex In-vitro Diagnostic Services SWOT Analysis Table 121. Sysmex Recent Developments Table 122. Thermofisher Company Details Table 123. Thermofisher Business Overview Table 124. Thermofisher In-vitro Diagnostic Services Product and Services Table 125. Thermofisher In-vitro Diagnostic Services Revenue in In-vitro Diagnostic Services Business (2017-2022) & (US$ Million) Table 126. Thermofisher Recent Developments Table 127. In-vitro Diagnostic Services Market Trends Table 128. In-vitro Diagnostic Services Market Drivers Table 129. In-vitro Diagnostic Services Market Challenges Table 130. In-vitro Diagnostic Services Market Restraints Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global In-vitro Diagnostic Services Sales Market Share by Type: 2021 VS 2028 Figure 2. Infectious Testing Features Figure 3. Diabetes Testing Features Figure 4. Molecular Testing Features Figure 5. Tissue Testing Features Figure 6. Global In-vitro Diagnostic Services Sales Market Share by Application: 2021 VS 2028 Figure 7. Hospitals Case Studies Figure 8. Point-Of-Care Testing Case Studies Figure 9. Laboratories Case Studies Figure 10. Academic Institutes Case Studies Figure 11. In-vitro Diagnostic Services Report Years Considered Figure 12. Global In-vitro Diagnostic Services Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global In-vitro Diagnostic Services Market Size 2017-2028 (US$ Million) Figure 14. Global In-vitro Diagnostic Services Market Size Market Share by Region: 2021 VS 2028 Figure 15. Global In-vitro Diagnostic Services Revenue Market Share by Region in 2017 VS 2022 Figure 16. Global Top 10 In-vitro Diagnostic Services Countries Ranking by Market Size (US$ Million) in 2021 Figure 17. Global In-vitro Diagnostic Services Market Share by Players in 2021 Figure 18. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2021) Figure 19. The Top 10 and 5 Players Market Share by In-vitro Diagnostic Services Revenue in 2021 Figure 20. North America In-vitro Diagnostic Services Revenue Market Share by Company in 2021 Figure 21. North America In-vitro Diagnostic Services Revenue Market Share by Type (2017-2028) Figure 22. North America In-vitro Diagnostic Services Revenue Market Share by Application (2017-2028) Figure 23. North America In-vitro Diagnostic Services Revenue Share by Country (2017-2028) Figure 24. United States In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 25. Canada In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 26. Mexico In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 27. Europe In-vitro Diagnostic Services Revenue Market Share by Company in 2021 Figure 28. Europe In-vitro Diagnostic Services Revenue Market Share by Type (2017-2028) Figure 29. Europe In-vitro Diagnostic Services Revenue Market Share by Application (2017-2028) Figure 30. Europe In-vitro Diagnostic Services Revenue Share by Country (2017-2028) Figure 31. Germany In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 32. France In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 33. UK In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 34. Italy In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 35. Russia In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 36. Asia Pacific In-vitro Diagnostic Services Revenue Market Share by Company in 2021 Figure 37. Asia Pacific In-vitro Diagnostic Services Revenue Market Share by Type (2017-2028) Figure 38. Asia Pacific In-vitro Diagnostic Services Revenue Market Share by Application (2017-2028) Figure 39. Asia Pacific In-vitro Diagnostic Services Revenue Share by Region (2017-2028) Figure 40. China In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 41. Japan In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 42. South Korea In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 43. India In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 44. Australia In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 45. China Taiwan In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 46. Indonesia In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 47. Thailand In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 48. Malaysia In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 49. Latin America In-vitro Diagnostic Services Revenue Market Share by Company in 2021 Figure 50. Latin America In-vitro Diagnostic Services Revenue Market Share by Type (2017-2028) Figure 51. Latin America In-vitro Diagnostic Services Revenue Market Share by Application (2017-2028) Figure 52. Latin America In-vitro Diagnostic Services Revenue Share by Country (2017-2028) Figure 53. Mexico In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 54. Brazil In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 55. Argentina In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 56. Middle East and Africa In-vitro Diagnostic Services Revenue Market Share by Company in 2021 Figure 57. Middle East and Africa In-vitro Diagnostic Services Revenue Market Share by Type (2017-2028) Figure 58. Middle East and Africa In-vitro Diagnostic Services Revenue Market Share by Application (2017-2028) Figure 59. Middle East and Africa In-vitro Diagnostic Services Revenue Share by Country (2017-2028) Figure 60. Turkey In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 61. Saudi Arabia In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 62. UAE In-vitro Diagnostic Services Revenue (2017-2028) & (US$ Million) Figure 63. BioRad Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 64. DexCom Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 65. Nova Biomedical Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 66. OraSure Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 67. Pearl Pathways Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 68. Phenomenex Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 69. Qiagen Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 70. Roche Diagnostics Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 71. Siemens Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 72. Sysmex Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 73. Thermofisher Revenue Growth Rate in In-vitro Diagnostic Services Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Infectious Testing Diabetes Testing Molecular Testing Tissue Testing